IMPULSIVE-COMPULSIVE DISORDERS IN PARKINSON'S DISEASE. CLINICAL CASES
https://doi.org/10.17650/1818-8338-2015-9-3-52-56
Abstract
Objective – a description of clinical cases of impulsivecompulsive disorders in Parkinson,s disease.
The first clinical case. Patient N., 75 years old, suffering for 15 years from Parkinson,s disease, akineticrigid form of the disease, stage 4 by Hyun–Yar. Since 2009, he received levodopa/carbidopa 250/25 mg 5 times/day (daily dose of 1250 mg of levodopa); pramipexole 3.5 mg per day (daily dose 3.5 mg), amantadine sulfate 100 mg 5 times/day (daily dose 500 mg). While taking antiparkinsonian drugs the patient developed behavioral disorders such as dopamine disregulatory syndrome combined with punding, hypersexuality and compulsive shopping accompanied by visual hallucinations. The total equivalent dose of levodopa was 1600 mg per day.
The second clinical case. Patient R., 52 years old, suffers from Parkinson,s disease about 5 years, a mixed form. She complained of slowness of movement, tremor in her left hand, sleep disturbances, poor mood. The clinic was appointed piribedil 50 mg 3 times per day. Despite the fact that the patient took only one of dopaminergic drugs in a therapeutic daily dose, she developed impulsivecompulsive disorder as hyper sexuality, compulsive shopping and binge eating.
Results. In the first clinical case for correction of behavioral disorders in patients with Parkinson,s disease levodopa/carbidopa dose was reduced to 750 mg per day (3/4 Tab. 4 times a day); added to levodopa/benserazide dispersible 100 mg morning and levodopa/benserazide 100 mg before sleep (total dose of levodopa of 950 mg per day). Amantadine sulfate and pramipexole were canceled. It was added to the therapy of atypical neuroleptic clozapine dose 6,25 mg overnight. After 3 months marked improvement, regressed visual hallucina tions, improved family relationships, background mood became more stable. The patient continue to sing karaoke, but this hobby has be come less intrusive.
In the second clinical event correction impulsivecompulsive disorders piribedil was replaced with pramipexole 1.5 mg prolonged form one time a day. At the control examination after 3 months behavioral disorders completely regressed.
Conclusion. This article describes two clinical cases of impulsivecompulsive disorders in patients with Parkinson s disease, methods of di agnosis and correction capabilities of these disorders.
About the Authors
N. V. Fedorova
Department of Neurology, Russian Medical Academy of Postgraduate Education, Ministry of Health of Russia, 2/1 Barrikadnaya St., Moscow, 125993, Russia
Russian Federation
Russian Federation
A. V. Nikitina
Department of Neurology, Russian Medical Academy of Postgraduate Education, Ministry of Health of Russia, 2/1 Barrikadnaya St., Moscow, 125993, Russia
Russian Federation
Russian Federation
References
1. Voon V., Fernagut P.O., Wickens J. et al. Chronic dopaminergic stimulation in Parkinson,s disease: from dyskinesias to impulse control disorders. Lancet Neurol 2009;8(12):1140–9.
2. Weintraub D., Siderowf A.D., Potenza M.N. et al. Association of dopamine agonist use with impulsive control disorders in Parkinson,s disease. Arch Neurol 2006;63(7):969–73.
3. Pontone G., Williams J.R., Bassett S.S., Marsh L. Clinical features associated with impulse control disorders in Parkinson,s disease. Neurology 2006;67(7):1258–61.
4. Lim S.Y., Evans A.H., Miyasaki J.M. Impulse control and related disorders in Parkinson,s disease. Ann N Y Acad Sci 2008;1142:85–107.
5. Uitti R.J., Tanner C.M., Rajput A.H. et al. Hypersexuality with antiparkinsonian therapy. Clin Neuropharmacol 1989;12(5):375–83. ,
6. Giovannoni G., O Sullivan J.D., Turner K. et al. Hedonistic homeostatic dysregulation in patients with Parkinson,s disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 2000;68(4):423–8.
7. Voon V., Hassan K., Zurowski M. et al. Prevalence of repetitive and reward-seeking behaviors in Parkinson,s disease. Neurology 2006;67(7):1254–7.
8. Ferrara J.M., Stacy M. Impulse-control disorders in Parkinson,s disease. CNS Spectr 2008;13(8):690–8.
9. Driver-Dunckley E., Samanta J., Stacy M. Pathological gambling associated with dopamine agonist therapy in Parkinson,s disease. Neurology 2003;61(3):422–3.
10. Diagnostic and statistical manual of mental disorders. Text Revision: DSM–IV-TR. Fourth Edition. Washington: American Psychiatric Publishing, 2000.
11. Park A., Stacy M. Dopamine-induced nonmotor symptoms of Parkinson,s disease. Parkinsons Dis 2011;201. Article ID 485063 doi:10.4061/2011/485063.
12. Wise R.A. Dopamine, learning and motivation. Nat Rev Neurosci 2004;5(6):483–94.
13. Weintraub D., Hoops S., Shea J.A. et al. Validation of the questionnaire for impulsive - compulsive disorders in Parkinson,s disease. Mov Disord 2009;24(10):1461–7.
14. Lee J.Y., Kim J.M., Kim J.W. et al. Association between the dose of dopaminergic medication and the behavioral disturbances in Parkinson disease. Parkinsonism Relat Disord 2010;16(3):202–7.
15. Herzog J., Valkmann J., Krack P. et al. Two-year follow-up of subthalamic deep brain stimulation in Parkinson,s disease. Mov Disord 2003;18(11):1332–7.
16. Hobson D.E., Lang A.E., Martin W.R. et al. Excessive daytime sleepiness and suddenonset sleep in Parkinson,s disease: a survey by the Canadian Movement Disorders Group. JAMA 2005;287(4):455–63.
17. Evans A.H., Lees A.J. Dopamine, dysregulation syndrome in Parkinson s disease. Curr Opin Neurol 2004;17(4):393–8.
18. Evans A.H., Katzenschlagen R., Pavior D. et al. Punding in Parkinson,s disease: its relation to the dopamine dysregulation syndrome. Mov Disord 2004;19(4):397–405.
19. Funkiewiez A., Ardouin C., Caputo E. et al. Long term of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson,s disease. J Neurol Neurosurg Psychiatry 2004;75(6):834–9. Никитина А.В., Федорова Н.В. Импульсивно-конвульсивный синдром при болезни Паркинсона. Журнал неврологии и психиатрии им. С.С. Корсакова. 2013;113(7;2):32–8. [Nikitina A.V., Fyodorova N.V. Impulsively and convulsive syndrome with Parkinson,s disease. Zhournal Nevrologii i Psikhiatrii im. S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatrics 2013;113(7;2):32–8. (In Russ.)].
20. Diagnostic and statistical manual of mental disorders. Version IV (DSM–IV). Washington, DC: American Psychyatric Association, 1994.
21. Voon V., Fox S.H. Medication-related impulse control and repetitive behaviors in Parkinson,s disease. Arch Neurol 2007;64(8);1089–96.
22. McElroy S.L., Keck P.E. Jr., Pope H.G. Jr. et al. Compulsive buying: a report of 20 cases. J Clin Psychiatry 1994;55(6):242–8.
Review
For citations:
Fedorova N.V., Nikitina A.V. IMPULSIVE-COMPULSIVE DISORDERS IN PARKINSON'S DISEASE. CLINICAL CASES. The Clinician. 2015;9(3):52-56. (In Russ.) https://doi.org/10.17650/1818-8338-2015-9-3-52-56
Views:
1557
Email this article 